TROMBETTA, Maddalena
 Distribuzione geografica
Continente #
NA - Nord America 7.498
EU - Europa 6.031
AS - Asia 4.079
SA - Sud America 612
Continente sconosciuto - Info sul continente non disponibili 268
AF - Africa 135
OC - Oceania 12
Totale 18.635
Nazione #
US - Stati Uniti d'America 7.230
RU - Federazione Russa 2.230
GB - Regno Unito 1.531
SG - Singapore 1.510
CN - Cina 1.082
IT - Italia 680
BR - Brasile 480
VN - Vietnam 408
HK - Hong Kong 303
DE - Germania 298
SE - Svezia 289
FR - Francia 252
FI - Finlandia 238
IE - Irlanda 201
BD - Bangladesh 190
KR - Corea 165
CA - Canada 144
IN - India 93
JP - Giappone 59
UA - Ucraina 58
MX - Messico 53
NL - Olanda 50
ID - Indonesia 46
PK - Pakistan 45
AR - Argentina 44
PL - Polonia 41
TR - Turchia 35
ZA - Sudafrica 28
EC - Ecuador 24
NG - Nigeria 24
AT - Austria 23
IQ - Iraq 21
CR - Costa Rica 20
ES - Italia 20
BE - Belgio 19
CO - Colombia 18
GR - Grecia 16
IL - Israele 13
SA - Arabia Saudita 13
UZ - Uzbekistan 13
BJ - Benin 12
EG - Egitto 12
PY - Paraguay 12
CL - Cile 11
CW - ???statistics.table.value.countryCode.CW??? 11
LT - Lituania 11
AU - Australia 10
CZ - Repubblica Ceca 10
DZ - Algeria 10
PH - Filippine 9
VE - Venezuela 9
GH - Ghana 8
JM - Giamaica 8
JO - Giordania 8
TG - Togo 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
GT - Guatemala 7
HN - Honduras 7
IR - Iran 7
MA - Marocco 7
RO - Romania 7
TH - Thailandia 7
NI - Nicaragua 6
UY - Uruguay 6
BG - Bulgaria 5
CH - Svizzera 5
DK - Danimarca 5
EE - Estonia 5
KG - Kirghizistan 5
NO - Norvegia 5
PR - Porto Rico 5
SC - Seychelles 5
AL - Albania 4
BO - Bolivia 4
ET - Etiopia 4
HU - Ungheria 4
KE - Kenya 4
LV - Lettonia 4
MD - Moldavia 4
MY - Malesia 4
NP - Nepal 4
PE - Perù 4
RS - Serbia 4
SV - El Salvador 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
CY - Cipro 3
DO - Repubblica Dominicana 3
GP - Guadalupe 3
LB - Libano 3
LK - Sri Lanka 3
PT - Portogallo 3
AO - Angola 2
BY - Bielorussia 2
HR - Croazia 2
KH - Cambogia 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
Totale 18.352
Città #
Ashburn 1.343
Southend 1.335
Dallas 904
Moscow 810
Singapore 742
San Jose 634
Chandler 536
Jacksonville 320
Hong Kong 295
Beijing 234
Verona 233
Woodbridge 233
New York 220
Ann Arbor 207
Dublin 201
Council Bluffs 190
Houston 158
Los Angeles 148
The Dalles 139
Ho Chi Minh City 120
Helsinki 91
Santa Clara 85
Wilmington 85
Hanoi 79
Lawrence 77
Princeton 77
Milan 71
Jinan 67
Munich 66
Buffalo 60
Nanjing 53
Seoul 52
São Paulo 52
Tokyo 50
Orem 48
Shenyang 45
Boardman 41
Turku 41
Dong Ket 36
Falkenstein 35
Frankfurt am Main 35
Redondo Beach 35
Toronto 35
Warsaw 35
London 31
Montreal 31
Phoenix 29
Sindelfingen 29
Tianjin 28
Bologna 27
Denver 27
Hebei 26
Redmond 26
Chicago 25
Columbus 24
Jakarta 24
Zhengzhou 24
Atlanta 23
Brooklyn 23
Rome 23
Rio de Janeiro 22
Amsterdam 21
Nanchang 21
Chennai 20
Lancaster 20
San Francisco 20
Boston 19
Brussels 19
Haiphong 19
North Bergen 19
Romola 19
Hangzhou 18
San José 18
Abuja 17
Mianwali 17
Nuremberg 17
Stockholm 17
Taiyuan 16
Brasília 15
Changsha 15
Dearborn 15
Haikou 15
Johannesburg 15
Kent 15
Shanghai 15
Vienna 15
Washington 15
Da Nang 14
Seattle 14
Dhaka 13
Mexico City 13
Paris 13
Redwood City 13
Tashkent 13
Cotonou 12
Hyderabad 12
Mumbai 12
Taizhou 12
Vancouver 12
Ankara 11
Totale 11.411
Nome #
American Diabetes Association 75th Scientific Meeting - Epidemiology/Genetics Section; Poster 1563-P: Pancreatic Beta-Cell Function, Insulin Sensitivity, and Metabolic Phenotypes in Type 2 Diabetes at the Time of Diagnosis—The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 798
Common Variants Associated to Type 2 Diabetes in the Italian Population 511
"Presence and titer of GAD antibodies are determinants of beta cell function in patients with newly diagnosed type 2 diabetes mellitus: further insights in the metabolic phenotype of LADA patients" 279
VARIABLES INFLUENCING THE OPTIMAL SAMPLING DURATION OF INTERMITTENTLY-SCANNED CONTINUOUS GLUCOSE MONITORING TO ASSESS 90 DAYS OF GLYCEMIA RISK INDEX. FINDINGS FROM A MULTICENTRIC REAL-WORLD STUDY. 268
Long-Acting GLP-1 Receptor Agonist Exenatide Influence on the Autonomic Cardiac Sympatho-Vagal Balance 263
A low "genetic load" of risk variants for type 2 diabetes is associated to better beta cell function in patients with newly diagnosed type 2 diabetes 256
Abstracts of 51st EASD Annual Meeting 251
11-6: CONTINUOUS GLUCOSE MONITORING AND ASSESSMENT OF LONG-TERM ISLET FUNCTION IN AUTOLOGOUS ISLET TRANSPLANTATION AFTER TOTAL PANCREATECTOMY FOR PANCREATIC NEOPLASIA: PRELIMINARY DATA FROM THE VERONA COHORT 245
A renal genetic risk score (GRS) is associated with kidney dysfunction in people with type 2 diabetes 245
Confronto delle variazioni acute della glicemia indotte dall'esercizio fisico aerobico o di forza muscolare: studio mediante holter glicemico 237
CACNA1E variants affect beta cell function in patients with newly diagnosed type 2 diabetes. the Verona newly diagnosed type 2 diabetes study (VNDS) 3. 234
Differences in the acute effects of aerobic and resistance exercise in subjects with type 2 diabetes: results from the RAED2 randomized trial 227
Association of free-living physical activity measures with metabolic phenotypes in type 2 diabetes at the time of diagnosis. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 227
Increased aortic stiffness index in patients with type 1 diabetes without cardiovascular disease compared to controls 227
Assessement of 1th and snd phase of insulin secretion during OGTT and IVGTT 226
Relationship of Chronic Vascular Complications with Beta-Cell Dysfunction and Insulin Resistance in Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 224
Genetic variability of G6PC2 influences beta cell function and insulin sensitivity in patients with newly diagnosed type 2 diabetes 223
Nonalcoholic Fatty Liver Disease Is Independently Associated With an Increased Incidence of Chronic Kidney Disease in Patients With Type 1 Diabetes. 221
Association between subclinical left ventricular systolic dysfunction and glycemic control in asymptomatic type 2 diabetic patients with preserved left ventricular function 221
A longitudinal study of glucose tolerance in cystic fibrosis: the central role of beta cell functional mass 218
Body mass index is a potential modifier of the influence on beta cell function exerted by SLC30A8 and KCNJ11 diabetes risk variants in patients with newly diagnosed type 2 diabetes 216
Diabetic foot complicated by vertebral osteomyelitis and epidural abscess 216
PPARG2 Pro12Ala and ADAMTS9 rs4607103 as "insulin resistance loci" and "insulin secretion loci" in Italian individuals. The GENFIEV study and the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 4. 214
Potential role of MTNR1B locus in regulating beta cell function and glucose levels in patients with newly diagnosed type 2 diabetes 212
Interleukin-6 as a potential positive modulator of human beta-cell function: an exploratory analysis-the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 6 210
A parsimonious model of a mixed-meal test in patients with type 1 diabetes in insulin pump therapy 209
Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9 208
Metabolic effects of aerobic training and resistance training in type 2 diabetic subjects: a randomized controlled trial (the RAED2 study). 206
Prevalence of Cardiovascular Autonomic Neuropathy in a Cohort of Patients With Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 206
Aerobic and resistence exercise have different short-term effect on glucose levels in type 2 diabetes subject 205
Lower levels of 25-hydroxyvitamin D3 are associated with a higher prevalence of microvascular complications in patients with type 2 diabetes. 205
Confronto degli effetti metabolici dell'esercizio aerobico e dell'esercizio di forza nel diabete tipo 2 200
Variants in CACNA1E affect beta cell function and glucose homeostasis in newly diagnosed type 2 diabetes patients 199
Cutaneous squamous carcinoma in a patient with diabetic foot: an unusual evolution of a frequent complication 199
Differences in the acute effects of aerobic and resistance exercise in subjects with type 2 diabetes: Results from the RAED2 randomized trial - Note in: Riddell et al., Physical activity and exercise 198
Effects of angiotensin II receptor inhibition on insulin-induced endothelial dysfunction in humans. 196
Variants and haplotypes of TCF7L2 are associated with beta cell function in patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS).1. 194
Is common genetic variation at IRS1, ENPP1 and TRIB3 loci associated with cardiometabolic phenotypes in type 2 diabetes? An exploratory analysis of the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 5 193
Insulin sensitivity and beta-cell function: Relationships to glycemic control in newly diagnosed Type 2 diabetic patients 192
In patients with newly-diagnosed type 2 diabetes beta cell function is an independent predictor of glucose control evolution over 18 months 190
Continuous Glucose Monitoring and Long-Term Assessment of Islet Function in Autologous Islet Transplantation after Total Pancreatectomy for Neoplasm: Preliminary Insights from a Prospective Study 189
Relation of serum gamma-glutamyltransferase to atherogenic dyslipidemia and glycemic control in type 2 diabetes. 189
Accuracy of CGM Systems During Continuous and Interval Exercise in Adults with Type 1 Diabetes 189
Influence of health locus of control and fear of hypoglycaemia on glycaemic control and treatment satisfaction in people with Type 1 diabetes on insulin pump therapy 186
Growing up with type 1 diabetes mellitus: Data from the Verona Diabetes Transition Project 186
Beta-cell function across the spectrum of glucose tolerance in obese youth. 184
Effects of Semaglutide on Glycemic Control and Weight Loss in a Patient with Prader-Willi Syndrome: A Case Report 184
Haplotypes of the genes (GCK and G6PC2) underlying the glucose/glucose-6-phosphate cycle are associated with pancreatic beta cell glucose sensitivity in patients with newly diagnosed type 2 diabetes from the VNDS study (VNDS 11) 183
Impaired Aortic Valve Growth in Type 1 Diabetes Mellitus 180
Increased prevalence of chronic kidney disease in patients with type 1 diabetes and non-alcoholic fatty liver. 176
PPARgamma Pro12Ala and ADAMTS9 rs4607103 are determinants of insulin sensitivity in both non-diabetic and type 2 diabetic Italian subjects 175
Defects in the dynamic control of beta cell function and in glucose effectiveness underly the initial decline in intravenous glucose tolerance of obese European children 173
Contribution of β-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: Role of severity of liver disease 172
“Genetic Load” of diabetes risk alleles affects beta-cell function in patients with newly diagnosed type 2 diabetes 171
Estimated peak systolic pulmonary artery pressure in young non-complicated patients with type 1 diabetes 171
Glomerular filtration rate decline in T2DM following diagnosis. The Verona newly diagnosed diabetes study-12 170
Left ventricular chamber dilation and filling pressure may help to categorise patients with type 2 diabetes 169
A sub-analysis of the SAGE study in Italy indicates good glycemic control in type 1 diabetes 168
Quantitation of the roles played by the main determinants of meal glucose tolerance in patients with type 1 diabetes on insulin pump therapy 168
Variants of GCKR affect both beta cell and kidney function in patients with newly diagnosed type 2 diabetes. The Verona Newly diagnosed type diabets study (VNDS). 2. 167
Evidence of left atrial remodeling and left ventricular diastolic dysfunction in type 2 diabetes mellitus with preserved systolic function 166
61st EASD Annual Meeting of the European Association for the Study of Diabetes SO 019 It's beta cell replacement time: 402 - Continuous glucose monitoring and assessment of islet function in autologous islet transplantation after total pancreatectomy for pancreatic neoplasia: preliminary data from the Verona cohort 164
Increased prevalence of cardiovascular disease in type 1 diabetic patients with non-alcoholic fatty liver disease. 164
Role of monogenic diabetes genes on beta cell function in Italian patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 13 163
Metabolic control analysis (MCA) of intravenous glucose tolerance in healthy humans. 157
Changes induced by metabolic surgery on the main components of glucose/insulin system in patients with diabetes and obesity 153
Impact of CFTR Modulators on Beta-Cell Function in Children and Young Adults with Cystic Fibrosis 151
Pathogenetic Mechanisms and Cardiovascular Risk: Differences between HbA1c and oral glucose tolerance test for the diagnosis of glucose tolerance. 148
A Randomized Crossover Trial Comparing Glucose Control During Postprandial Moderate Aerobic Activity and High-Intensity Interval Training in Adults With Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System 142
Relationship between soluble CD40 ligand and gamma-glutamyltransferase concentrations in non-drinking, young type 1 diabetic individuals 142
Different Times for Different Metrics: Predicting 90 Days of Intermittently Scanned Continuous Glucose Monitoring Data in Subjects With Type 1 Diabetes on Multiple Daily Injection Therapy. Findings From a Multicentric Real-World Study 141
Evaluating endothelial function of the common carotid artery: An in vivo human model. 141
Crosstalk between genetic variability of adiponectin and leptin, glucose‐insulin system and subclinical atherosclerosis in patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study 14 138
Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion 137
61st EASD Annual Meeting of the European Association for the Study of Diabetes SO 077 Hi Hypo :) I would like to know you better 854 - Detecting hypoglycaemia with glycaemia risk index in adults with type 1 diabetes using continuous glucose monitoring and multiple daily injection therapy: a multicentric real-world study 135
Uric acid is a biomarker of beta cell function in patients with newly diagnosed type 2 diabetes 134
Central role of the β-cell in driving regression of diabetes after liver transplantation in cirrhotic patients 134
Type 2 Diabetes Mellitus: a Disease of the Governance of the Glucose-Insulin System. An Experimental Metabolic Control Analysis Study. 133
Heritability of model-derived parameters of beta cell secretion during intravenous and oral glucose tolerance tests: a study of twins. 132
Echocardiographic parameters according to insulin dose in young patients affected by type 1 diabetes 131
Continuous subcutaneous insulin infusion in Italy: third national survey. 130
G Protein-Coupled Receptors and the Rise of Type 2 Diabetes in Children 129
Review article: type 2 diabetes and chronic liver disease in the Verona Diabetes Study 129
Continuous intraperitoneal insulin infusion: an alternative route for insulin delivery in type 1 diabetes 128
Markers of subclinical vascular damage in young adults with type 1 diabetes mellitus: the role of central blood pressure 126
Insulin sensitivity is correlated with subcutaneous but not visceral body fat in overweight and obese prepubertal children. 125
Interactions of the Osteokines, Glucose/Insulin System and Vascular Risk Networks in Patients With Newly Diagnosed Type 2 Diabetes (VNDS 15) 123
Metformin is associated with low levels of vitamin B12 with no effect on other vitamin levels. A selective action of metformin 122
Loss of ZnT8 function protects against diabetes by enhanced insulin secretion 122
Depressive symptoms and glycaemic control in adults with type 1 diabetes: an exploratory study on the role of family functioning 122
Insulin resistance and beta‐cell dysfunction in newly diagnosed type 2 diabetes: Expression, aggregation and predominance. Verona Newly Diagnosed Type 2 Diabetes Study 10 121
Variability of body weight, pulse pressure and glycemia strongly predict total mortality in elderly type 2 diabetic patients. The Verona Diabetes Study. 121
Methods to assess in vivo insulin sensitivity and insulin secretion 119
Metabolic abnormalities underlying the different prediabetic phenotypes in obese adolescents. 117
SARS-CoV-2 and COVID-19 in diabetes mellitus. Population-based study on ascertained infections, hospital admissions and mortality in an Italian region with ∼5 million inhabitants and ∼250,000 diabetic people 115
Lower heart rate variability, an index of worse autonomic function, is associated with worse beta cell response to a glycemic load in vivo—The Maastricht Study 107
Glucose tolerance stages in Cystic Fibrosis are idenfied by a unique pattern of defects of Beta-cell function 106
Assessing attitudes towards insulin pump therapy in adults with type 1 diabetes: Italian validation of the Insulin Pump Attitudes Questionnaire (IT-IPA questionnaire) 105
Correction to: Assessing attitudes towards insulin pump therapy in adults with type 1 diabetes: Italian validation of the Insulin Pump Attitudes Questionnaire (IT‑IPA questionnaire) 96
Elevated 1-Hour Postload Plasma Glucose Levels Identify Subjects With Normal Glucose Tolerance but Impaired β-Cell Function, Insulin Resistance, and Worse Cardiovascular Risk Profile: The GENFIEV Study. 94
Totale 18.482
Categoria #
all - tutte 58.696
article - articoli 41.854
book - libri 0
conference - conferenze 16.369
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 473
Totale 117.392


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022349 0 0 0 0 23 36 13 32 23 18 54 150
2022/20231.414 99 195 118 252 127 322 17 80 138 14 34 18
2023/20241.301 35 60 73 101 100 215 31 308 10 130 164 74
2024/20252.351 95 133 114 446 97 89 151 78 387 136 212 413
2025/20267.992 456 521 772 1.426 1.926 513 617 382 466 446 209 258
2026/20271.628 130 196 281 880 141 0 0 0 0 0 0 0
Totale 18.635